The Authors Reply:  by Praga, Manuel & González, Ester
suggest a modiﬁed version of the previously published
Table 11 underscoring the existence of this very interesting
pattern (Table 1).
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The Authors Reply: We appreciate the interest of Airoldi
et al.1 in our review ‘Acute interstitial nephritis’.2 The
uncommon clinical cases on which they comment (interstitial
vasculitis without glomerular involvement) have a great
clinical and pathogenic interest. However, their inclusion as
another type of acute interstitial nephritis (AIN) is, in our
opinion, debatable. AIN is usually deﬁned as a syndrome with
different etiologies and is characterized by the presence of
inﬂammatory inﬁltrates and edema within the interstitium,
whereas glomeruli and vessels are distinctly normal.2,3
This deﬁnition is useful to distinguish true AIN from those
interstitial inﬁltrates and edema that very frequently accom-
pany many forms of glomerulonephritis and vasculitis. For
instance, in the study of Hauer et al.,4 interstitial inﬁltrates
were found in 92% of 173 patients with antineutrophil
cytoplasmic antibody–associated vasculitis. The distinction
between true AIN and interstitial inﬂammation accompany-
ing other renal diseases (glomerulonephritis, vasculitis, and
acute tubular necrosis), although difﬁcult to establish in
some cases, is convenient not only for academic purposes:
prognosis and treatment of these entities is very different. For
all these reasons, we would prefer ‘interstitial vasculitis’ as the
most appropriate and precise diagnosis for the patients
reported by Airoldi et al. To be included among the different
causes of AIN, they could be classiﬁed within a subgroup
of ‘interstitial nephritis accompanying glomerulonephritis
and vasculitis’.
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Corin: a serine protease
To The Editor:We read with great interest the commentary in
a recent issue of Kidney International, in which Klein1
provided an insightful discussion on potential roles of corin
and atrial natriuretic peptide (ANP) in regulating sodium
reabsorption in nephrotic syndrome.2 In this article, however,
corin was indicated as a ‘serine/threonine’ protease.1 Unlike
serine/threonine protein kinases, which phosphorylate the OH
group of serine or threonine residues, corin is a serine protease,
that is, proteolytic enzyme that cleaves peptide bonds within a
polypeptide.3 The catalytic activity of corin is mediated by a
reactive Ser residue that is part of the catalytic triad (Asp, His,
and Ser) in its protease domain (Figure 1). As a trypsin-like
serine protease, corin has a substrate speciﬁcity favoring Arg or
Figure 1 |A molecular model of the corin protease domain.
The protease domain of corin is shown in a three-dimensional
structure similar to that of chymotrypsin. b-Sheets and a-helices
are shown in yellow and red, respectively. The catalytic residues
Asp, His, and Ser are shown in purple.
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